Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Renal Failure

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 80 articles:
HTML format

Single Articles

    January 2022
  1. SANCHEZ-TOCINO ML, Miranda-Serrano B, Gracia-Iguacel C, de-Alba-Penaranda AM, et al
    Sarcopenia assessed by 4-step EWGSOP2 in elderly hemodialysis patients: Feasibility and limitations.
    PLoS One. 2022;17:e0261459.
    PubMed     Abstract available

  2. SHIRAISHI T, Tominaga T, Nonaka T, Hashimoto S, et al
    Effect of hemodialysis on short-term outcomes after colon cancer surgery.
    PLoS One. 2022;17:e0262531.
    PubMed     Abstract available

  3. KANG SH, Do JY, Kim JC
    Impedance-derived phase angle is associated with muscle mass, strength, quality of life, and clinical outcomes in maintenance hemodialysis patients.
    PLoS One. 2022;17:e0261070.
    PubMed     Abstract available

  4. AFGHAHI H, Nasic S, Peters B, Rydell H, et al
    Long-term glycemic variability and the risk of mortality in diabetic patients receiving peritoneal dialysis.
    PLoS One. 2022;17:e0262880.
    PubMed     Abstract available

  5. ZHENG S, Yang J, Tan TC, Belani S, et al
    Dialysis therapy and mortality in older adults with heart failure and advanced chronic kidney disease: A high-dimensional propensity-matched cohort study.
    PLoS One. 2022;17:e0262706.
    PubMed     Abstract available

  6. LIN ML, Chu KH
    The experience of urgent dialysis patients with end-stage renal disease: A qualitative study.
    PLoS One. 2022;17:e0261941.
    PubMed     Abstract available

  7. LAFTA A, Ukrainetz J, Davison S, Thompson S, et al
    Inter- and intradialytic fluid volume changes and vascular stiffness parameters in patients on hemodialysis.
    PLoS One. 2022;17:e0262519.
    PubMed     Abstract available

  8. BASSI J, Giannini O, Silacci-Fregni C, Pertusini L, et al
    Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.
    PLoS One. 2022;17:e0263328.
    PubMed     Abstract available

  9. JIANG C, Zheng Q
    Outcomes of peritoneal dialysis in elderly vs non-elderly patients: A systemic review and meta-analysis.
    PLoS One. 2022;17:e0263534.
    PubMed     Abstract available

  10. PANEERSELVAM GS, Aftab RA, Sirisinghe RG, Lai PSM, et al
    Study protocol: Effectiveness of patient centered pharmacist care in improving medication adherence, clinical parameters and quality of life among hemodialysis patients.
    PLoS One. 2022;17:e0263412.
    PubMed     Abstract available

  11. KANG T, Hu Y, Huang X, Amoah AN, et al
    Serum uric acid level and all-cause and cardiovascular mortality in peritoneal dialysis patients: A systematic review and dose-response meta-analysis of cohort studies.
    PLoS One. 2022;17:e0264340.
    PubMed     Abstract available

  12. LEE CT, Lee CC, Wu MJ, Chiu YW, et al
    Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial.
    PLoS One. 2022;17:e0264727.
    PubMed     Abstract available

  13. WONG K, Caskey FJ, Casula A, Ben-Shlomo Y, et al
    The UK Chinese population with kidney failure: Clinical characteristics, management and access to kidney transplantation using 20 years of UK Renal Registry and NHS Blood and Transplant data.
    PLoS One. 2022;17:e0264313.
    PubMed     Abstract available

  14. MIKUTEIT M, Gueler F, Pollmann I, Pflugrad H, et al
    Assessment of cognitive functioning after living kidney donation: A cross-sectional pilot study.
    PLoS One. 2022;17:e0264284.
    PubMed     Abstract available

  15. LI D, Li Y, Zeng H, Wu Y, et al
    Risk factors for Encapsulating Peritoneal Sclerosis in patients undergoing peritoneal dialysis: A meta-analysis.
    PLoS One. 2022;17:e0265584.
    PubMed     Abstract available

  16. ABDELAZEEM B, Shehata J, Abbas KS, El-Shahat NA, et al
    The efficacy and safety of roxadustat for the treatment of anemia in non-dialysis dependent chronic kidney disease patients: An updated systematic review and meta-analysis of randomized clinical trials.
    PLoS One. 2022;17:e0266243.
    PubMed     Abstract available

  17. WANG M, Hsu HC, Yu MC, Wang IK, et al
    Impact of kidney size on the outcome of diabetic patients receiving hemodialysis.
    PLoS One. 2022;17:e0266231.
    PubMed     Abstract available

  18. MARUYAMA Y, Nakayama M, Abe M, Yokoo T, et al
    Association between serum beta2-microglobulin and mortality in Japanese peritoneal dialysis patients: A cohort study.
    PLoS One. 2022;17:e0266882.
    PubMed     Abstract available

  19. MONTOYA URREGO D, Vanegas JM, Jimenez JN
    The remarkable genetic relationship between Staphylococcus aureus isolates from hemodialysis patients and their household contacts: Homes as an important source of colonization and dissemination.
    PLoS One. 2022;17:e0267276.
    PubMed     Abstract available

  20. LAMBERT K, Lightfoot CJ, Jegatheesan DK, Gabrys I, et al
    Physical activity and exercise recommendations for people receiving dialysis: A scoping review.
    PLoS One. 2022;17:e0267290.
    PubMed     Abstract available

  21. BARRETT PM, McCarthy FP, Evans M, Kublickas M, et al
    Does gestational diabetes increase the risk of maternal kidney disease? A Swedish national cohort study.
    PLoS One. 2022;17:e0264992.
    PubMed     Abstract available

  22. GOMES CLR, Yamane TLC, Ruzany F, Rocco Suassuna JH, et al
    A real-world prospective study on dialysis-requiring acute kidney injury.
    PLoS One. 2022;17:e0267712.
    PubMed     Abstract available

  23. TORRES I, Sippy R, Bardosh KL, Bhargava R, et al
    Chronic kidney disease in Ecuador: An epidemiological and health system analysis of an emerging public health crisis.
    PLoS One. 2022;17:e0265395.
    PubMed     Abstract available

  24. MIKAMI R, Mizutani K, Matsuyama Y, Gohda T, et al
    Association of type 2 diabetes with periodontitis and tooth loss in patients undergoing hemodialysis.
    PLoS One. 2022;17:e0267494.
    PubMed     Abstract available

  25. KANJANABUCH T, Nopsopon T, Chatsuwan T, Purisinsith S, et al
    Predictors and outcomes of peritoneal dialysis-related infections due to filamentous molds (MycoPDICS).
    PLoS One. 2022;17:e0268823.
    PubMed     Abstract available

  26. SALAS-GAMA K, Onakpoya IJ, Coronado Daza J, Perera R, et al
    Recommendations of high-quality clinical practice guidelines related to the process of starting dialysis: A systematic review.
    PLoS One. 2022;17:e0266202.
    PubMed     Abstract available

  27. INAGAKI K, Tawada N, Takanashi M, Akahori T, et al
    The association between body mass index and all-cause mortality in Japanese patients with incident hemodialysis.
    PLoS One. 2022;17:e0269849.
    PubMed     Abstract available

  28. GUEDES M, Wallim L, Guetter CR, Jiao Y, et al
    Fatigue in incident peritoneal dialysis and mortality: A real-world side-by-side study in Brazil and the United States.
    PLoS One. 2022;17:e0270214.
    PubMed     Abstract available

  29. NGUYEN TTN, Liang SY, Liu CY, Chien CH, et al
    Self-care self-efficacy and depression associated with quality of life among patients undergoing hemodialysis in Vietnam.
    PLoS One. 2022;17:e0270100.
    PubMed     Abstract available

  30. QUICKEN S, Mees B, Zonnebeld N, Tordoir J, et al
    A realistic arteriovenous dialysis graft model for hemodynamic simulations.
    PLoS One. 2022;17:e0269825.
    PubMed     Abstract available

  31. CHEWCHARAT A, Chewcharat P, Liu W, Cellini J, et al
    The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis.
    PLoS One. 2022;17:e0271307.
    PubMed     Abstract available

  32. ETO E, Maeda Y, Sonoda N, Nakashima N, et al
    Association of serum total bilirubin levels with progressive renal decline and end-stage kidney disease: 10-year observational cohort study in Japanese patients with diabetes.
    PLoS One. 2022;17:e0271179.
    PubMed     Abstract available

  33. LIM DKE, Boyd JH, Thomas E, Chakera A, et al
    Prediction models used in the progression of chronic kidney disease: A scoping review.
    PLoS One. 2022;17:e0271619.
    PubMed     Abstract available

  34. ARYAIE M, Sharifi H, Saber A, Salehi F, et al
    Longitudinal causal effect of modified creatinine index on all-cause mortality in patients with end-stage renal disease: Accounting for time-varying confounders using G-estimation.
    PLoS One. 2022;17:e0272212.
    PubMed     Abstract available

  35. ROUMELIOTIS S, Roumeliotis A, Georgianos PI, Thodis E, et al
    VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial.
    PLoS One. 2022;17:e0273102.
    PubMed     Abstract available

  36. OOI SW, Yeh ST, Chang YH, Li CY, et al
    Low mean HbA1c does not increase all-cause and cardiovascular mortality in patients with diabetes: Effect-modifications by anemia and chronic kidney disease stages.
    PLoS One. 2022;17:e0272137.
    PubMed     Abstract available

  37. CHANG YK, Fan HC, Lin CC, Wang YH, et al
    Association between atrial fibrillation and risk of end-stage renal disease among adults with diabetes mellitus.
    PLoS One. 2022;17:e0273646.
    PubMed     Abstract available

  38. ATAEI FAR H, Hassani AH, Taghavi L, Fazeli M, et al
    Electro dialysis reversal (EDR) performance for reject brine treatment of reverse osmosis desalination system.
    PLoS One. 2022;17:e0273240.
    PubMed     Abstract available

  39. CUTTING RB, Webster AC, Cross NB, Dunckley H, et al
    AcceSS and Equity in Transplantation (ASSET) New Zealand: Protocol for population-wide data linkage platform to investigate equity in access to kidney failure health services in New Zealand.
    PLoS One. 2022;17:e0273371.
    PubMed     Abstract available

  40. STORRAR J, Chinnadurai R, Sinha S, Kalra PA, et al
    The epidemiology and evolution of IgA nephropathy over two decades: A single centre experience.
    PLoS One. 2022;17:e0268421.
    PubMed     Abstract available

  41. YANG IN, Lu CL, Tang HJ, Kuo YC, et al
    Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis.
    PLoS One. 2022;17:e0273676.
    PubMed     Abstract available

  42. OROZCO T, Segal E, Hinkamp C, Olaoye O, et al
    Development and validation of an end stage kidney disease awareness survey: Item difficulty and discrimination indices.
    PLoS One. 2022;17:e0269488.
    PubMed     Abstract available

  43. PICELLI DE AZEVEDO MG, Salgueiro Geraldes S, Bilbau Sant'Anna P, Poloni Batista B, et al
    C-reactive protein concentrations are higher in dogs with stage IV chronic kidney disease treated with intermittent hemodialysis.
    PLoS One. 2022;17:e0274510.
    PubMed     Abstract available

  44. KELLER MM, Lucas T, Cadzow R, Feeley T, et al
    Patient perceptions by race of educational animations about living kidney donation made for a diverse population.
    PLoS One. 2022;17:e0266867.
    PubMed     Abstract available

  45. HNYNN SI PE, Gair R, Barnes T, Dunn L, et al
    Symptom burden according to dialysis day of the week in three times a week haemodialysis patients.
    PLoS One. 2022;17:e0274599.
    PubMed     Abstract available

  46. CHANG HH, Wu CL, Tsai CC, Chiu PF, et al
    Association between predialysis creatinine and mortality in acute kidney injury patients requiring dialysis.
    PLoS One. 2022;17:e0274883.
    PubMed     Abstract available

  47. CHEN SJ, Chiang HY, Chen PS, Chang SN, et al
    Association of poorly controlled HbA1c with increased risk of progression to end-stage kidney disease and all-cause mortality in patients with diabetes and chronic kidney disease.
    PLoS One. 2022;17:e0274605.
    PubMed     Abstract available

  48. AHN JW, Lee SM, Seo YH
    Factors associated with self-care behavior in patients with pre-dialysis or dialysis-dependent chronic kidney disease.
    PLoS One. 2022;17:e0274454.
    PubMed     Abstract available

  49. PARK DY, An S, Hanna JM, Wang SY, et al
    Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal disease.
    PLoS One. 2022;17:e0276394.
    PubMed     Abstract available

  50. COUCHOUD C, Ecochard R, Prezelin-Reydit M, Lobbedez T, et al
    Functional representation of the network organisation of dialysis activities in France: A novel level for assessing quality of care.
    PLoS One. 2022;17:e0276068.
    PubMed     Abstract available

  51. SOUSA H, Ribeiro O, Costa E, Christensen AJ, et al
    Establishing the criterion validity of self-report measures of adherence in hemodialysis through associations with clinical biomarkers: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0276163.
    PubMed     Abstract available

  52. RIOS P, Sola L, Ferreiro A, Silvarino R, et al
    Adherence to multidisciplinary care in a prospective chronic kidney disease cohort is associated with better outcomes.
    PLoS One. 2022;17:e0266617.
    PubMed     Abstract available

  53. STORRAR J, Gill-Taylor T, Chinnadurai R, Chrysochou C, et al
    A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades.
    PLoS One. 2022;17:e0276053.
    PubMed     Abstract available

  54. CHOI SH, Kim M, Kim H, Kim DH, et al
    Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation.
    PLoS One. 2022;17:e0275103.
    PubMed     Abstract available

  55. SANTIN M, Perez-Recio S, Grijota MD, Anibarro L, et al
    Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial).
    PLoS One. 2022;17:e0276387.
    PubMed     Abstract available

  56. BLAIR C, Shields J, Mullan R, Johnston W, et al
    Exploring the lived experience of renal cachexia for individuals with end-stage renal disease and the interrelated experience of their carers: Study protocol.
    PLoS One. 2022;17:e0277241.
    PubMed     Abstract available

  57. HUANG YT, Jiang MY, Hwang JC
    Albumin to prealbumin ratio in peritoneal dialysis patients: Clinical implication and outcome prediction.
    PLoS One. 2022;17:e0276159.
    PubMed     Abstract available

  58. KILLIAN AC, Reed RD, McLeod MC, MacLennan PA, et al
    Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort study.
    PLoS One. 2022;17:e0276882.
    PubMed     Abstract available

    January 2021
  59. JARVISALO MJ, Jokihaka V, Hakamaki M, Lankinen R, et al
    Dental health assessed using panoramic radiograph and adverse events in chronic kidney disease stage 4-5 patients transitioning to dialysis and transplantation-A prospective cohort study.
    PLoS One. 2021;16:e0258055.
    PubMed     Abstract available

  60. ALVAREZ-VILLARREAL M, Velarde-Garcia JF, Garcia-Bravo C, Carrasco-Garrido P, et al
    The experience of being a mother with end stage renal disease: A qualitative study of women receiving treatment at an ambulatory dialysis unit.
    PLoS One. 2021;16:e0257691.
    PubMed     Abstract available

  61. BELKADI A, Thareja G, Dadhania D, Lee JR, et al
    Deep sequencing of DNA from urine of kidney allograft recipients to estimate donor/recipient-specific DNA fractions.
    PLoS One. 2021;16:e0249930.
    PubMed     Abstract available

  62. HIRAMITSU T, Tomosugi T, Okada M, Futamura K, et al
    Intact parathyroid hormone levels localize causative glands in persistent or recurrent renal hyperparathyroidism: A retrospective cohort study.
    PLoS One. 2021;16:e0248366.
    PubMed     Abstract available

  63. PIATKOWSKA E, Paleczny J, Dydak K, Letachowicz K, et al
    Antimicrobial activity of hemodialysis catheter lock solutions in relation to other compounds with antiseptic properties.
    PLoS One. 2021;16:e0258148.
    PubMed     Abstract available

  64. BACHELET T, Bourdenx JP, Martinez C, Mucha S, et al
    Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times.
    PLoS One. 2021;16:e0257646.
    PubMed     Abstract available

  65. PERUZZO D, Guedes M, Larkin JW, Yokoyama G, et al
    Peritoneal dialysis modality transition and impact on phosphate and potassium serum levels.
    PLoS One. 2021;16:e0257140.
    PubMed     Abstract available

  66. WATANABE K, Nakayama M, Yamamoto T, Yamada G, et al
    Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study.
    PLoS One. 2021;16:e0249240.
    PubMed     Abstract available

  67. YABE H, Kono K, Yamaguchi T, Ishikawa Y, et al
    Effects of intradialytic exercise for advanced-age patients undergoing hemodialysis: A randomized controlled trial.
    PLoS One. 2021;16:e0257918.
    PubMed     Abstract available

  68. UEDA Y, Ookawara S, Ito K, Sasabuchi Y, et al
    Association between hepatic oxygenation on near-infrared spectroscopy and clinical factors in patients undergoing hemodialysis.
    PLoS One. 2021;16:e0259064.
    PubMed     Abstract available

  69. TOKUYAMA A, Kanda E, Itano S, Kondo M, et al
    Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia.
    PLoS One. 2021;16:e0251554.
    PubMed     Abstract available

  70. JABBOUR E, Futterer C, Zach S, Kalsch AI, et al
    Implantation of a peritoneal dialysis catheter in patients with ESRD using local anesthesia and Remifentanil.
    PLoS One. 2021;16:e0259351.
    PubMed     Abstract available

  71. TOFIGHI M, Asgary A, Merchant AA, Shafiee MA, et al
    Modelling COVID-19 transmission in a hemodialysis centre using simulation generated contacts matrices.
    PLoS One. 2021;16:e0259970.
    PubMed     Abstract available

  72. WALBAUM M, Scholes S, Rojas R, Mindell JS, et al
    Projection of the health and economic impacts of Chronic kidney disease in the Chilean population.
    PLoS One. 2021;16:e0256680.
    PubMed     Abstract available

  73. JUN MR, Kim MG, Han KS, Park JE, et al
    Potency of propofol for inducing loss of consciousness in end-stage kidney disease patients.
    PLoS One. 2021;16:e0254520.
    PubMed     Abstract available

  74. LIONAKI S, Makropoulos I, Panagiotellis K, Vlachopanos G, et al
    Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
    PLoS One. 2021;16:e0253337.
    PubMed     Abstract available

  75. YU JY, Kim JS, Hong CM, Lee KY, et al
    Psychological distress of patients with end-stage kidney disease undergoing dialysis during the 2019 coronavirus disease pandemic: A cross-sectional study in a University Hospital.
    PLoS One. 2021;16:e0260929.
    PubMed     Abstract available

  76. SUZUKI N, Hitomi Y, Takata H, Ushiya S, et al
    Association between salt intake and long-term mortality in hemodialysis patients: A retrospective cohort study.
    PLoS One. 2021;16:e0260671.
    PubMed     Abstract available

  77. VERA M, Cheak BB, Chmelickova H, Bavanandan S, et al
    Current clinical practice in adapted automated peritoneal dialysis (aAPD)-A prospective, non-interventional study.
    PLoS One. 2021;16:e0258440.
    PubMed     Abstract available

  78. MANDAI S, Ando F, Mori T, Susa K, et al
    Burden of kidney disease on the discrepancy between reasons for hospital admission and death: An observational cohort study.
    PLoS One. 2021;16:e0258846.
    PubMed     Abstract available

  79. NIELSEN MB, Jespersen B, Birn H, Krogstrup NV, et al
    Elevated plasma free thiols are associated with early and one-year graft function in renal transplant recipients.
    PLoS One. 2021;16:e0255930.
    PubMed     Abstract available

  80. BOEHMER KR, Pine KH, Whitman S, Organick P, et al
    Do patients with high versus low treatment and illness burden have different needs? A mixed-methods study of patients living on dialysis.
    PLoS One. 2021;16:e0260914.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.